Prolepsia forecastYes / no

Will the NHS England waiting list for planned care be below 7 million in December 2027?

As of 16 November 2026, Prolepsia puts the chance of yes at 32%.

32%chance of yes

Yes 32%No 68%
Prolepsia forecast made

How Prolepsia reasons

The report Prolepsia wrote with this forecast.

How forecasts are made · Track record

TL;DR

The forecast is 31.7% for Yes and 68.3% for No. A December 2027 waiting list below 7 million requires a sustained improvement in the balance between new referrals and pathway removals, rather than simply more appointments or better waiting-time percentages.

Key evidence

  • The starting gap is substantial. September 2026 had 7,375,866 incomplete RTT pathways, including estimates for missing providers. Reaching the maximum qualifying count of 6,999,999 requires a reduction of 375,867 across 15 monthly changes. The list was only 12,283 lower than a year earlier (NHS England overview series).
  • Recent progress has stalled. The list rose from 7,106,091 in March 2026 to 7,375,866 in September. Over the latest corresponding twelve-month periods, working-day-adjusted starts grew 3.5%, versus 2.4% for completed pathways. Completions are not all removals, so that difference cannot be translated directly into future list growth (official statistical release).
  • There are credible recovery mechanisms. Official allocations provide higher elective/diagnostic funding in 2027/28 (allocations table). Payment rules also reward eligible patient-not-present work that closes pathways, including triage, validation and results review (payment guidance). Neither establishes a verified national reduction large enough to secure the outcome.

Uncertainties

The central uncertainty is whether total removals sustainably accelerate relative to starts. Funding, referral reform and list management could deliver that improvement; demand growth, staffing constraints, winter pressures or renewed industrial disruption could prevent it.

Reporting also matters. September’s total included 301,542 estimated pathways for non-reporting providers. Returning submissions replace those estimates; they do not automatically remove those pathways from the list (official statistical release). Revisions can move the final count either way.

The question resolves on the unrounded December 2027 pathway total, not unique patients, an earlier crossing below the threshold, or performance against waiting-time targets.

Read the full report

TL;DR

The forecast is 31.7% for Yes and 68.3% for No. Treat a December 2027 waiting list at or above 7 million as the more likely outcome. The decisive test is sustained excess pathway removals over new starts, not growth in appointments or improvement in waiting-time percentages.

Context

This question concerns England’s incomplete consultant-led referral-to-treatment pathways at the end of December 2027. It counts outstanding treatment pathways, not individual patients: one person can have more than one pathway. The qualifying total includes official estimates for non-reporting providers, and exactly 7,000,000 resolves No. The unrounded count and the specified six-month revision window determine the final result.

As of the forecast date, November 16, 2026, the latest observation was September 2026, published on November 12. It recorded 7,375,866 pathways. Reaching the maximum qualifying total of 6,999,999 therefore requires a reduction of 375,867 across 15 monthly changes. The list is below its historical peak, but the latest annual decline was just 12,283 pathways (NHS England overview series; statistical release).

Evidence

The historical starting point argues against assuming an automatic recovery. The list grew sharply before falling in the two latest completed calendar years. Those reductions establish that progress is possible. They do not establish that progress is fast enough. The following history also shows why a December endpoint matters: autumn reductions have been common, but not universal. These September-to-December changes combine seasonality with the underlying trend; they are not a pure seasonal effect (official overview workbook).

Year December pathways September-to-December change
2017 3,995,928 −75,173
2018 4,284,808 −37,378
2019 4,565,238 −1,972
2020 4,587,286 +166,449
2021 6,071,293 +211,247
2022 7,200,033 +58,083
2023 7,607,585 −160,988
2024 7,463,085 −108,464
2025 7,290,880 −97,269

The recent monthly history is more revealing than the peak-to-present comparison. It shows a decline into early 2026, followed by a rebound. All figures below use the same September 2026 publication vintage and include missing-provider estimates. This avoids mixing later revised counts with original press-release figures (official overview workbook).

Month 2023 2024 2025 2026
January 7,213,120 7,575,914 7,427,669 7,247,214
February 7,217,871 7,536,907 7,401,153 7,216,208
March 7,331,186 7,538,830 7,418,598 7,106,091
April 7,415,352 7,570,371 7,389,065 7,218,231
May 7,475,194 7,601,650 7,355,950 7,278,384
June 7,574,649 7,621,297 7,367,836 7,272,291
July 7,674,305 7,623,081 7,390,279 7,328,252
August 7,745,784 7,641,774 7,403,612 7,370,100
September 7,768,573 7,571,549 7,388,149 7,375,866
October 7,703,867 7,541,371 7,395,445 —
November 7,613,842 7,479,867 7,308,928 —
December 7,607,585 7,463,085 7,290,880 —

The list increased by 269,775 between March and September 2026. That reversal matters more for the near-term outlook than the fact that the list remains below its September 2023 peak. The Institute for Government attributes part of the early-2026 improvement to temporary sprint funding. I read this as evidence against treating the spring reduction as a permanent operating rate, not as evidence that further reductions are impossible (overview series; Performance Tracker).

The underlying arithmetic is simple. The list falls when total removals exceed new starts. Gross activity can rise while the list barely changes because demand rises too. The available trailing-year history illustrates that problem; figures are approximate millions of pathways for twelve-month periods ending in September (official overview workbook).

Period ending New starts Reported completions Total removals
September 2023 20.45 17.08 19.83
September 2024 20.69 17.88 20.88
September 2025 21.21 18.32 21.39
September 2026 21.96 18.75 21.97

The latest annual balance was almost flat. The official release reports working-day-adjusted growth of 3.5% in starts and 2.4% in completed pathways across the corresponding trailing twelve-month periods. That is a cautionary demand-and-activity signal, but not a complete stock-flow calculation: reported completions exclude other removals. The residual also contains reporting effects and must not be labelled entirely as validation (official statistical release).

Independent analysis reaches a similar diagnosis. The Health Foundation found that referral and removal growth had broadly matched over its comparison period. Its continuation analysis supports caution about a rapid automatic decline, but remains conditional on unchanged trends rather than proof that policy cannot improve performance (Health Foundation analysis).

There are concrete reasons to allow for stronger recovery. The national allocations table lists additional non-recurrent elective/diagnostic funding of £323.092 million in 2026/27 and £1,130.837 million in 2027/28. These allocations support delivery capacity, but do not establish a specific incremental pathway reduction. They are also allocations within the NHS settlement, not amounts to add again to overall spending (core allocations).

Payment reform offers another route. The final payment rules cover eligible patient-not-present work that stops an RTT clock, including triage, validation and diagnostic-results review, with implementation required by July 1, 2026. This can reduce the measured stock without an equivalent increase in operations or conventional outpatient appointments. No verified national incremental-removal effect is established, so the mechanism supports upside without guaranteeing its size (payment guidance).

Referral infrastructure is changing too. Single Point of Access functionality entered the e-referral service in October 2026, after the latest RTT observation. For advice requests converted into referrals, the original request date starts the pathway. That limits the idea that referrals can simply be held outside the clock indefinitely. Better triage can still help, but advice-request diversion is not the same as a permanent reduction in treatment demand (NHS Digital explanation).

Local evidence shows feasibility, not a national effect size. Bedfordshire reported clock stops running 5.3% above their historical weekly rate since early September, alongside 1,363 backlog removals. The same papers describe staffing difficulties and winter risks. This is a credible example of improvement with constraints, rather than a basis for extrapolating one trust’s results across England (Bedfordshire board papers).

What's non-obvious

Better waiting-time performance does not necessarily mean a smaller list. The national objectives concern the share treated within 18 weeks: 70% by March 2027 and 92% by March 2029. Those are not numerical December 2027 list-size commitments. A system can improve the age distribution of outstanding waits while new referrals keep the total high. Conversely, valid pathway closures can reduce the total without a matching increase in surgery. The question therefore turns on the entire pathway balance, not a single activity or performance headline (planning framework).

The other easily missed point is the treatment of missing providers. September’s 7,375,866 total comprised 7,074,324 submitted pathways and 301,542 estimated pathways, covering six non-reporting trusts. Those estimates belong in the qualifying count. Restored reporting replaces estimates with actual submissions; it does not automatically erase the estimated pathways. A lower reported-only series is therefore not evidence of an equally low national list (official statistical release).

Uncertainties

The largest gap is the national effect of the operational reforms. There is no verified national December 2027 list-size trajectory, audited Single Point of Access adoption total, or causal estimate of additional pathway closures from the new payment mechanism. Sustained, seasonally comparable improvements in starts and total removals would provide stronger evidence than announcements or isolated local successes.

Demand and capacity remain uncertain. Referral growth can absorb extra activity. Staffing constraints, winter pressures and financial limits can interrupt recovery. Near-term industrial-action evidence is less adverse than older notices imply: the planned November consultant action was paused, but that is not a permanent settlement (NHS Employers announcement).

Finally, estimates and revisions can move the published level in either direction. Methodological changes require a comparable official series under the resolution rules. These are genuine endpoint risks, especially near a strict threshold, but they provide no basis for assuming an automatic downward correction. The evidence supports No as the more likely outcome while leaving a substantial chance that sustained recovery delivers Yes.

Forecast history

How Prolepsia’s forecast has movedOne forecast so far: 32% on 16 Nov 2026.
DateForecast
32% chance of yes

Sources Prolepsia read

  1. Statistics » Consultant-led Referral to Treatment Waiting Times Data 2026-27www.england.nhs.uk
  2. Performance Tracker 2026: NHS | Institute for Governmentwww.instituteforgovernment.org.uk
  3. Two years down, three to go: is progress on waiting times stalling? - The Health Foundationwww.health.org.uk
  4. Single Point of Access (SPoA) services in e-RS - NHS England Digitaldigital.nhs.uk
  5. Bedfordshire board paperswww.bedfordshirehospitals.nhs.uk
  6. Consultant strike action paused | NHS Employerswww.nhsemployers.org
  7. northeastnorthcumbria.nhs.ukwww.northeastnorthcumbria.nhs.uk
  8. Budget 2026 (HTML) - GOV.UKwww.gov.uk
  9. From 52-week unvalidated backlog to fully validated front door: 30% reduction in referrals requiring a first appointment | Consultant Connectwww.consultantconnect.org.uk
  10. Consultants in England pause strike actionwww.bma.org.uk

The question

This question asks whether the NHS England waiting list for planned (elective) care will fall below 7 million by the end of December 2027. The waiting list is defined as the total number of incomplete consultant-led referral-to-treatment (RTT) pathways in England, as reported in NHS England's official monthly RTT waiting times statistics. An incomplete pathway represents a referral for which a patient has not yet started treatment. Because an individual patient may be waiting for multiple treatments, the number of pathways is greater than the number of unique patients. As of November 16, 2026, the latest available figures are for September 2026, published by NHS England on November 12, 2026. These show approximately 7.4 million incomplete RTT pathways, corresponding to an estimated 6.2 million individual patients. This compares with approximately 7.3 million pathways in December 2025. The waiting list therefore remains above the 7 million threshold, despite reductions from its historical peak of approximately 7.77 million in September 2023. The forecast concerns the waiting list specifically at the end of December 2027, rather than whether the list falls below 7 million at any point before then. The relevant figures are expected to be published in early 2028 as part of NHS England's regular monthly statistical releases. The primary source is NHS England's Consultant-led Referral to Treatment Waiting Times statistics, available at https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/.

How it resolves

The question resolves YES if the official NHS England consultant-led Referral to Treatment (RTT) waiting times statistics for December 2027 report fewer than 7,000,000 incomplete RTT pathways across England at the end of that month. The question resolves NO if the reported total is 7,000,000 or greater. A figure of exactly 7,000,000 therefore resolves NO. The authoritative measure will be the England-level total of incomplete RTT pathways, including NHS England's estimates for non-reporting trusts, as published in the official December 2027 RTT statistical release. The national total will be taken from the England-level RTT overview time series or equivalent official dataset, using the commissioner-based measure where applicable. The underlying unrounded count will determine the outcome, rather than a rounded figure expressed in millions in a statistical press release. The observation date is December 31, 2027. Resolution will occur after NHS England publishes the statistics covering December 2027, expected in early 2028. If the initial publication is subsequently revised, the latest official revision available within six months of the initial release will be used as the final figure. The question may be provisionally assessed using the initial release but will be finalised once this revision window has closed. If NHS England changes its statistical methodology, reporting structure, or institutional arrangements before December 2027, the question will use the official successor series that most closely preserves the existing definition of incomplete consultant-led RTT pathways in England. Where both the original and revised methodologies are published, the figure calculated using the original methodology will take precedence to maintain comparability. If the December 2027 statistics are not published within 12 months of the end of the reporting period, or if methodological changes make it impossible to identify a reasonably comparable national waiting-list total, the question will be annulled rather than resolved YES or NO. If the original NHS England statistics are transferred to another government body, the successor's official publication will be accepted.

Fine print

The question concerns England only, not the entire United Kingdom. Waiting lists for Scotland, Wales, and Northern Ireland are excluded. The measure counts incomplete RTT pathways rather than unique patients, completed treatments, or the number of people waiting longer than a particular threshold. It includes eligible consultant-led elective care pathways regardless of how long patients have been waiting. Separate waiting lists for services outside the scope of consultant-led RTT statistics, such as community health services, are excluded unless already incorporated into the official RTT series under the applicable methodology. The threshold is strictly below 7 million, meaning that the maximum qualifying value is 6,999,999 pathways. A temporary reduction below 7 million during an earlier month in 2027 will not be sufficient for a YES resolution if the December 2027 total is 7 million or higher. Conversely, the question can resolve YES even if the waiting list remained above 7 million throughout most of 2027, provided it is below the threshold at the end of December. Only officially reported figures, including official estimates for missing provider submissions, will be used. Independent estimates, political announcements, or unofficial projections will not override the official statistical series.